Results 151 to 160 of about 418,298 (339)
Dynamics of urinary chloride and sodium and their link to decongestion in acute heart failure and preserved ejection fraction: NACLOCRo‐HF study
ESC Heart Failure, EarlyView.The study evaluated urinary chloride (uCl) and sodium (uNa) trajectories in 70 elderly patients hospitalized with acute heart failure and preserved ejection fraction (HFpEF). Urine samples were collected at baseline, 24, 48 and 72 h. A multiparametric approach assessed decongestion using the clinical congestion score (CCS), portal vein (PV) pulsatility Jorge Campos, Pau Llàcer, François Croset, Marina García, Carlos Pérez, Alberto Pérez, Marina Vergara, Paul Cevallos, Martín Fabregate, Cristina Fernández, Raúl Ruiz, Daniel Useros, Miriam Menacho, Miriam Domínguez, Esteban Pérez, Julio Núñez, Luis Manzano +16 morewiley +1 more sourceAcute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides
European Journal of Heart Failure, EarlyView.Cancer patients presenting to the emergency department ED with dyspnoea. Among 2153 patients presenting to the ED with dyspnea, 473 (22.0%) had an active or past cancer. Acute heart failure (AHF) was the most common final diagnosis in both groups. Pneumonia and cancer‐related dyspnoea were more common in cancer patients.Paolo Bima, Desirée Wussler, Pedro Lopez‐Ayala, Maria Belkin, Albina Nowak, Xueting Lin, Ivo Strebel, Fabiana Sgueglia, Eleni Michou, Androniki Papachristou, Laureve Chollet, Codruta Popescu, Nikola Kozhuharov, Samyut Shrestha, Gabriela Kuster, Katharina Rentsch, Arnold Von Eckardstein, Mascha Binder, Felix Mahfoud, Tobias Breidthardt, Christian Mueller +20 morewiley +1 more sourceAtrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC
European Journal of Heart Failure, EarlyView.The diagnosis of atrial cardiomyopathy (AtCM) requires electrical atrial dysfunction, with evidence of either mechanical atrial dysfunction, atrial enlargement, or excessive atrial fibrosis. The diagnostic cut‐points presented are for standard electrocardiogram and echocardiogram studies (see Figure 1 for further detail).Jerremy Weerts, Otilia Țica, Julia Aranyo, Christian Basile, Angelina Borizanova‐Petkova, Josip Andjelo Borovac, Massimiliano Camilli, Martin Eichenlaub, Emiliano Fiori, Tim Van Loon, Coenraad Withaar, Diana Zakarkaitė, Matthias D. Zink, Marianna Adamo, Alberto Aimo, Elena Arbelo, Felipe Bisbal Van Bylen, Dimitrios T. Farmakis, Dobromir Dobrev, Jelena Čelutkienė, Michael Böhm, Andrew Coats, Marco Metra, Giuseppe Rosano, Frank Ruschitzka, Antoni Bayes‐Genis, Dipak Kotecha +26 morewiley +1 more sourceRationale and design of the TRIC‐I‐HF‐DZHK24 (TRICuspid Intervention in Heart Failure) trial
European Journal of Heart Failure, EarlyView.Study overview of the TRIC‐I‐HF‐DZHK24 trial. HF, heart failure; HFH, heart failure hospitalization; QoL, quality of life; RHC, right heart catheterization; TR, tricuspid regurgitation; TTVI, transcatheter tricuspid valve intervention. Abstract Aims
Tricuspid regurgitation (TR) is a detrimental disease frequently diagnosed in patients with right‐sided ...Thomas J. Stocker, Tobias Geisler, Wolfgang Rottbauer, Edith Lubos, Christian Frerker, Niklas Schofer, Johanne Frank, Ralph Stephan von Bardeleben, Tobias Kister, Rico Osteresch, Alexander Lauten, Tienush Rassaf, Jürgen Rothe, David M. Leistner, Lukas Stolz, Victoria Kehl, Maria Grzeschniok, Andreas Hagendorff, Volker Rudolph, Stephan Baldus, Philipp Lurz, Steffen Massberg, Jörg Hausleiter, for the TRIC‐I‐HF‐DZHK24 Investigators, Jörg Hausleiter, Thomas J. Stocker, Steffen Massberg, Lukas Stolz, Michael Näbauer, Ludwig Weckbach, Philipp Doldi, Julia Novotny, Tobias Geisler, Meinrad Gawaz, Andreas Goldschmidt, Monika Zdanyte, Wolfgang Rottbauer, Mirjam Keßler, Edith Lubos, Christian Frerker, Roza Saraei, Ingo Eitel, Tobias Schmidt, Thomas Stiermaier, Momir Dejanovikj, Sebastian Kupp, Mulham Alhagi, Niklas Schofer, Daniel Kalbacher, Johanne Frank, Derk Frank, Matthias Lutz, Mohammed Saad, Stephan von Bardeleben, Philipp Lurz, Tobias Ruf, Theresa Gößler, Volker Rudolph, Kai Peter Friedrichs, Tanja Rudolph, Maria Ivannikova, Werner Scholtz, Hazem Omran, Tobias Kister, Holger Thiele, Rico Osteresch, Rainer Hambrecht, Alexander Lauten, Tienush Rassaf, Amir A. Mahabadi, Jürgen Rothe, Christian Besler, Mirjam Wild, Dirk Westermann, Nikolaus Löffelhardt, Roman Pfister, Stephan Baldus, Christos Iliadis, Dennis Mehrkens, Erion Xhepa, Michael Joner, Teresa Trenkwalder, Hector A. Covarrubias, Friederike Schürmann, Heribert Schunkert, David Leistner, Amin Polzin, Malte Kelm, Patrick Horn, Ralf Westenfeld, Eike Tigges, Georg Nickenig, Marcel Weber, Margarita Schulz, Johanna Vogelhuber, Dominik Nelles, Christian Butter, Mathias Konstandin, Norbert Frey, Philipp Nikolai, Raffi Bekeredjian, Alexander Wolf, Marc M. Vorpahl, Ulf Landmesser, Markus Reinthaler Fabian Barbieri, Joachim Schofer, Christina Brinkmann, Bernhard Unsöld, Kerstin Piayda, Sven Möbius‐Winkler, Christian Schulze +110 morewiley +1 more sourceRandomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial
European Journal of Heart Failure, EarlyView.EMPower the heArt of patients with TermInal Cancer using Cardiac medicines (EMPATICC). eGFR, estomated glomerular filtration rate; EP, endpoint; FCM, ferric carboxymaltose; LVEF, left ventricular ejection fraction; N‐terminal pro‐B‐type natriuretic peptide; PGA, patient global assessment; PoC, proof of concept; QoL, quality of life; UICC, Union for ...Markus S. Anker, Amir A. Mahabadi, Matthias Totzeck, Mitra Tewes, Raluca Mincu, Muhammad Shahzeb Khan, Javed Butler, Ulrich Keller, Johann Ahn, Lars Bullinger, Dominik P. Modest, Ulf Landmesser, Lorenz H. Lehmann, Sven Bercker, Ulrich Laufs, Michael Böhm, Bela Merkely, Monika Diek, Tim Heise, Martin Hellmich, Marius Placzek, Tim Friede, Stefan D. Anker, Tienush Rassaf +23 morewiley +1 more source
